Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition-Reference-Cited by-同舟云学术

Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition

Published:2021-12 Issue:6 Volume:100 Page:1214-1226
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Bai Yuntao,Kim Ji Young,Bisunke Bijay,Jayne Laura A.,Silvaroli Josie A.,Balzer Michael S.,Gandhi Megha,Huang Kevin M.,Sander Veronika,Prosek Jason,Cianciolo Rachel E.,Baker Sharyn D.,Sparreboom Alex,Jhaveri Kenar D.,Susztak Katalin,Bajwa Amandeep,Pabla Navjot Singh

Publisher

Elsevier BV

Subject

Nephrology

Reference72 articles.

1. The link between kidney disease and cancer: complications and treatment;Malyszko;Lancet,2020

2. Acute kidney injury;Bellomo;Lancet,2012

3. Reduced estimated GFR and cancer mortality;Iff;Am J Kidney Dis,2014

4. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone;Schwartz;Am J Med,1957

5. Hyponatremia in a patient with cancer;Uppal;Am J Kidney Dis,2020

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of RAF kinases and their inhibitors (2019–2023);European Journal of Medicinal Chemistry;2024-09

2. Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31;Journal of the American Society of Nephrology;2024-03-26

3. Tubular mitochondrial pyruvate carrier disruption elicits redox adaptations that protect from acute kidney injury;Molecular Metabolism;2024-01

4. Pharmacological approaches to understanding protein kinase signaling networks;Frontiers in Pharmacology;2023-12-14

5. Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced AKI;Journal of the American Society of Nephrology;2023-11-14